Credit: UT Southwestern Medical Center
Dr. Abhimanyu Garg examines Dwanna Swan, a generalized lipodystrophy patient whom he has been treating for 14 years. The drug that Mrs. Swan has been taking as part of a clinical trial, metreleptin, was approved by the FDA today for treatment of this rare disease.